Latest James Wells Stories
Top New Zealand IP law firm expands use of online technology to enhance service delivery for patent and trademark clients SAN MATEO, California, May 23, 2013 /PRNewswire/ -- CPA Global's First To File(R) [http://www.firsttofile.com ] (FTF), a leading provider of hosted intellectual property (IP) management technology, announced today that top New Zealand law firm James & Wells [http://www.jaws.co.nz ] Intellectual Property is expanding its use of FTF's Electronic File...
There is now relief for adult patients that need teeth correction but have reservations about traditional braces. A new technology and new tools for teeth straightening are available at South Charlotte Dentistry. Charlotte, NC (PRWEB) March 13, 2013 South Charlotte Dentist, Dr. James Wells announces the addition of a new teeth straightening technology to his practice. The Six Month Smiles® product line is a new tool in the dental field that allows patients to move through the teeth...
Dr. James Wells takes his commitment to his patients health one step further by quizzing them on any reported headaches or facial pain. He is paying particular attention to patients that complain about headaches or facial pain when they smile. Charlotte, North Carolina (PRWEB) February 21, 2013 When a patient enters South Charlotte Dentistry they are greeted by a pleasant receptionist, a dental assistant and then Dr. James Wells. By the time they get to the chair, they are probably asked...
CINCINNATI, Dec. 12, 2010 /PRNewswire-USNewswire/ -- For the first time, scientists have created functioning human intestinal tissue in the laboratory from pluripotent stem cells. In a study posted online Dec. 12 by Nature, scientists from Cincinnati Children's Hospital Medical Center say their findings will open the door to unprecedented studies of human intestinal development, function and disease. The process is also a significant step toward generating intestinal tissue for...
SOUTH SAN FRANCISCO, Calif., July 8 /PRNewswire/ -- Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases...
Scientists identified a master regulator gene for embryonic development of the pancreas, putting researchers closer to a possible cure for type1 diabetes. The disease occurs when the immune system attacks insulin producing beta cells in the pancreas, usually destroying them beyond repair before the illness is diagnosed.Besides having important implications in diabetes research, the study offers new insights into congenital birth defects involving the pancreas and biliary system by...
Scientists have identified a master regulator gene for early embryonic development of the pancreas and other organs, putting researchers closer to coaxing stem cells into pancreatic cells as a possible cure for type1 diabetes.Researchers at Cincinnati Children's Hospital Medical Center report their findings in the July 21 Developmental Cell.Besides having important implications in diabetes research, the study offers new insights into congenital birth defects involving the pancreas and biliary...
A new study has found that misconduct at research institutions within the United States may be more common than previously believed.  A survey conducted in 2006 of 2,212 mainly biomedical scientists at 605 universities and other research institutions showed that 9 percent reported they had personally witnessed fabrication, plagiarism or falsification. Many were hesitant to report the misconduct, the survey found.Thirty-seven percent of alleged misconduct cases were never reported to...
